What we say and what we mean when we say redundancy and robustness of the chemokine system – how CCR5 challenges these concepts
暂无分享,去创建一个
[1] A. Antonelli,et al. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis. , 2017, Autoimmunity reviews.
[2] S. Nam,et al. CCR5 deficiency induces astrocyte activation, Aβ deposit and impaired memory function , 2009, Neurobiology of Learning and Memory.
[3] A. Mantovani,et al. Redundancy and robustness versus division of labour and specialization in innate immunity. , 2017, Seminars in immunology.
[4] M. Sugiyama,et al. Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients. , 2018, JCI insight.
[5] L. Vangelista,et al. The Expanding Therapeutic Perspective of CCR5 Blockade , 2018, Front. Immunol..
[6] J. Chies,et al. CCR5 gene editing - Revisiting pros and cons of CCR5 absence. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[7] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[8] R. Nibbs,et al. A guide to chemokines and their receptors , 2018, The FEBS journal.
[9] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[10] David Cyranoski,et al. Genome-edited baby claim provokes international outcry , 2018, Nature.
[11] G. Graham,et al. Chemokine Receptor Redundancy and Specificity Are Context Dependent , 2019, Immunity.
[12] C. Hughes,et al. Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.
[13] C. Power. Knock out models to dissect chemokine receptor function in vivo. , 2003, Journal of immunological methods.
[14] Tracy M Handel,et al. Chemokine: receptor structure, interactions, and antagonism. , 2007, Annual review of immunology.
[15] T. Schall,et al. Overcoming hurdles in developing successful drugs targeting chemokine receptors , 2011, Nature Reviews Immunology.
[16] J. Chies,et al. Host immunogenetics in tick-borne encephalitis virus infection-The CCR5 crossroad. , 2019, Ticks and tick-borne diseases.
[17] A. Teixeira-Carvalho,et al. Analysis of the immunological biomarker profile during acute Zika virus infection reveals the overexpression of CXCL10, a chemokine linked to neuronal damage , 2018, Memorias do Instituto Oswaldo Cruz.
[18] Gérard Eberl. Robustness in living organisms is homeostasis. , 2018, Seminars in immunology.
[19] H. Lassmann,et al. CCR5 blockade for neuroinflammatory diseases — beyond control of HIV , 2016, Nature Reviews Neurology.
[20] A. Rodriguez-Frandsen,et al. CCR5 deficiency predisposes to fatal outcome in influenza virus infection. , 2015, The Journal of general virology.
[21] D. Y. Hwang,et al. CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function , 2016, OncoTarget.
[22] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[23] S. Benvenga,et al. Novel Therapies for Thyroid Autoimmune Diseases , 2016, Expert review of clinical pharmacology.
[24] P. Tak,et al. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[25] Ting Li,et al. Pleiotropy Complicates Human Gene Editing: CCR5Δ32 and Beyond , 2019, Front. Genet..
[26] A. Gholami,et al. CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis. , 2016, Circulation research.
[27] E. Lo,et al. Differential subnetwork of chemokines/cytokines in human, mouse, and rat brain cells after oxygen–glucose deprivation , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] D. McDermott,et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.
[29] A. Mantovani,et al. The chemokine system: redundancy for robust outputs. , 1999, Immunology today.
[30] A. Antonelli,et al. Chemokines in hyperthyroidism , 2019, Journal of clinical & translational endocrinology.
[31] Neha S. Gandhi,et al. Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are “More Equal” than Others , 2019, Molecules.
[32] Virginia Litwin,et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.
[33] D. Weissman,et al. Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration* , 2002, The Journal of Biological Chemistry.
[34] W. Ge,et al. The potential risks of C-C chemokine receptor 5-edited babies in bone development , 2019, Bone Research.
[35] N. Maeda,et al. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. , 2000, The American journal of pathology.
[36] Hideo Baba,et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. , 2018, Cancer treatment reviews.
[37] S. Kunkel,et al. CCR5 antagonists: the answer to inflammatory disease? , 2006, Expert opinion on therapeutic patents.
[38] David L. Woodland,et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. , 2008, Immunity.
[39] J. Chies,et al. High CXCL10/IP-10 levels are a hallmark in the clinical evolution of the HIV infection. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.